Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Days

Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Days

Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Days

Backers of Vaccitech estimate it could be a $1 billion company by year-end.

Backers of Vaccitech estimate it could be a $1 billion company by year-end.

Photo: john cairns/Agence France-Presse/Getty Images